-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's right to use underlying asset under operating lease.
-
Summary
-
Verve Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2024.
- Verve Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $79.9M, a 8.18% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)